Latest Transplant rejection Stories
Noninvasive Technology Can Be Used To Monitor Kidney Transplant Patients For Rejection ALPHARETTA, Ga., Feb.
HILDEN, Germany, and GERMANTOWN, Maryland, January 27, 2015 /PRNewswire/ -- - QuantiFERON Monitor (QFM(R)) launches in Europe for monitoring immune
HORSHOLM, Denmark, Jan. 14, 2015 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) (Veloxis) today confirmed that the U.S.
HORSHOLM, Denmark, Dec. 19, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) (Veloxis) today issued the following statement regarding an order issued by the U.S.
Mount Sinai researchers find variation in key gene in donor may accelerate scarring of transplanted kidney once in recipient New York, NY (PRWEB) December
A new study found in the latest issue of STEM CELLS Translational Medicine reports that researchers may have found a solution to the rejection of transplanted tissue that is used along with immuno-suppression
- Study published in American Journal of Transplantation - HORSHOLM, Denmark, Nov.
Oxford University scientists have shown that a powerful drug given at the time of a kidney transplant operation not only halves the early risk of rejection, but that it also allows a less toxic regimen of anti-rejection drugs to be used after the operation.
TOTOWA, N.J., July 28, 2014 /PRNewswire/ -- BiologicTx(®) announced their Discovery 2 Life((TM)) (D2L((TM))), a leading digital health platform designed to guide and support hospitals, clinicians
HORSHOLM, Denmark, July 28, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) and Chiesi Farmaceutici S.p.A.
- A serpent whose bite was fabled to produce intense thirst.